Combined treatment of inflammatory periodontal diseases

Treatment tactics for patients with inflammatory periodontal diseases continue to be the subject of discussion among specialists in the field. Technical-scientific progress offers safe technologies and methods for treating patients with periodontal pathologies. Currently, when various methods of treating inflammatory conditions of the periodontium are recognized, we come up with the proposal to implement a minimally invasive method of combined treatment. The combined treatment process includes the use of an autologous preparation - plasma platelets-enriched plasma (PEP) and hyperbaric oxygen. The treatment program consists of the injection of autologous plasma enriched in platelets into the periodontal tissues, once every 7 days in 3-4 sessions. In the interval between injections, we perform 2-3 sessions of per-mucosal, non-invasive hyperbaric oxygen infusion. A session lasts about 15-20 minutes. The injected autologous plasma is the patient’s „own product”, thus, it is not toxic and does not present adverse reactions. Moreover, it has a pronounced locoregional curative effect. Hyperbaric oxygen has a role in restoring the oxygenation of damaged cells, increasing blood circulation, and stimulating tissue function. As result of the combined treatment, we obtained not only the treatment of the inflammatory processes of the periodontium, but also triggered the physiological processes of restoring the structure of the periodontal tissues and the prevention of the bone tissue consistency loss.